ON-DEMAND WEBINAR
Rethinking Perfusion Imaging for Oncology Assessment in Brain

Using perfusion imaging for assessing brain tumors can be complicated as the imaging may suffer from artifacts and require manual steps while providing only limited information on tissue status in brain tumors.

In this webinar Professor Kim Beuschau Mouridsen gives an introduction to a new approach to perfusion imaging that allows to get unique insights into brain tissue oxygenation for reliable tumor grading and prognosis while using your existing imaging protocols.

Speaker

Kim Beuschau Mouridsen, Founder and CEO at Cercare Medical, Professor at Aarhus University

Kim Mouridsen, PhD, MSc is a Professor at Aarhus University. He is the head of Neuroimaging Methods at the Center for Functionally Integrative Neuroscience (CFIN) and MINDLab. Professor Mouridsen has published over 40 papers in peer-reviewed journals including Nature Medicine and holds 6 patent applications.

Ready to Transform Your Diagnostic Capabilities?

Join Us in Advancing Brain Health with Cutting-Edge Microvascular Modeling.
Contact Us Today to Learn More!
Contact us
Cercare Medical A/S
Inge Lehmanns Gade 10
8000 Aarhus C
Denmark

Solutions
Cercare Perfusion Neuro & Oncology Stroke Modules
Support
Assistance Instructions for Use
Company
Board Members Investors About News Privacy Policy Regulatory & Compliance
© 2024 Cercare Medical. All rights reserved.
TRY US

CLINICAL USE CASES AND TECHNICAL HIGHLIGHTS


CBCT PERFUSION IN THE ANGIO SUITE
CBCT Perfusion delivers CT-quality perfusion maps directly in the angio suite,
using standard C-arm systems. For the first time, clinicians can access
advanced tissue insights without interrupting care or delaying treatment.

CLINICAL USE CASES
  • Assess outcomes post-intervention: detect missed stenoses, distal occlusions, or microvascular disturbances.
  • Guide complementary therapies on the spot based on perfusion status.
  • May detect the no-reflow phenomenon — providing insight into cases where recovery may fail despite successful thrombectomy.
  • Potentially enables direct-to-angio workflows.

TECHNICAL HIGHLIGHTS
  • Full set of perfusion markers: CBF, CBV, MTT.
  • Advanced oxygen metabolism imaging: OEF, CMRO₂.
  • Reliable results with as few as 5 CBCT acquisitions (bolus injection timing protocol very important).
  • Integrated with Siemens and Philips systems; GE/Canon under evaluation.

CBCT Imaging

Side-by-side comparison: The left-hand side is the raw CBCT data, while the right-hand side panel is the pre-processed data.
Using CMN software in the angio suite delivers results comparable to conventional CT/MR perfusion.

Explore CMN!

Fast. Reliable. Personalized.

Discover how Cercare Medical Neurosuite (CMN) enhances post-processing images and provides actionable insights from advanced biomarkers - tailored to your workflow.

Fill-out the form below, and a representative will contact you.
Perfusion Summit 2026
Date: 26 March 2026, Thursday
Time: 10:15 - 17:40 (CET)
Venue: Concorde Hall, Hilton Paris Hotel, CDG
Participation is Optional

Hands-On Workshops
Date: 27 March 2026

Workshop selection is optional and does not confirm registration. Confirmation and further details will be provided in January 2026. Please note that seating is limited.
By participating in this event, you consent to the use of your image, voice, and likeness in photographs, and videos for promotional purposes, in accordance with GDPR regulations.

Sign up for the upcoming Perfusion & Metabolic Imaging Community (PMIC)



    Request a demo

    Let us give you a tour around our solution.

    Fill in your credentials, and a member of the Cercare Medical team will contact you with a date and time proposal that fits your schedule.



      })